K2M Group Holdings Inc. (NASDAQ:KTWO) shares traded down 1.8% on Wednesday . The stock traded as low as $16.55 and last traded at $16.80, with a volume of 105,967 shares traded. The stock had previously closed at $17.11.

Several research analysts have weighed in on the stock. Needham & Company LLC reiterated a “strong-buy” rating and issued a $22.00 price target (up from $21.00) on shares of K2M Group Holdings in a research report on Friday, August 5th. Oppenheimer Holdings Inc. restated an “outperform” rating on shares of K2M Group Holdings in a research report on Tuesday, July 19th. Gabelli initiated coverage on shares of K2M Group Holdings in a research report on Friday, September 16th. They set a “buy” rating and a $22.00 price objective on the stock. Barclays PLC raised their price objective on shares of K2M Group Holdings from $20.00 to $22.00 and gave the company an “overweight” rating in a research report on Thursday, August 4th. Finally, Zacks Investment Research upgraded shares of K2M Group Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, August 9th. Two research analysts have rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $22.17.

The company’s market capitalization is $716.89 million. The firm’s 50-day moving average is $16.62 and its 200-day moving average is $15.08.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/21/k2m-group-holdings-inc-ktwo-shares-down-1-8.html

K2M Group Holdings (NASDAQ:KTWO) last posted its earnings results on Wednesday, August 3rd. The medical device company reported ($0.27) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.28) by $0.01. K2M Group Holdings had a negative net margin of 17.79% and a negative return on equity of 12.90%. The firm earned $59.20 million during the quarter, compared to analysts’ expectations of $57.47 million. During the same period in the previous year, the business posted ($0.16) EPS. The business’s revenue was up 5.0% compared to the same quarter last year. Equities analysts predict that K2M Group Holdings Inc. will post ($1.09) EPS for the current fiscal year.

Institutional investors have recently bought and sold shares of the stock. Wellington Management Group LLP boosted its position in K2M Group Holdings by 44.5% in the first quarter. Wellington Management Group LLP now owns 2,110,822 shares of the medical device company’s stock valued at $31,303,000 after buying an additional 649,694 shares in the last quarter. Renaissance Technologies LLC boosted its position in K2M Group Holdings by 267.8% in the first quarter. Renaissance Technologies LLC now owns 220,300 shares of the medical device company’s stock valued at $3,267,000 after buying an additional 160,400 shares in the last quarter. M&T Bank Corp purchased a new position in K2M Group Holdings during the first quarter valued at about $241,000. Kennedy Capital Management Inc. purchased a new position in K2M Group Holdings during the first quarter valued at about $3,922,000. Finally, Bogle Investment Management L P DE purchased a new position in K2M Group Holdings during the first quarter valued at about $560,000. Hedge funds and other institutional investors own 62.37% of the company’s stock.

About K2M Group Holdings

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company’s spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions.

5 Day Chart for NASDAQ:KTWO

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.